Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ADAMTS17
REST API REST API
Homo sapiens
ADAMTS17 is differentially expressed in 121 experiments: 51 organism parts: bone marrow, cerebellum, ... (49 more);, 41 disease states: normal, control, ... (39 more);, 41 cell types 50 cell lines 15 compound treatments and 41 other conditions.
Synonyms FLJ32769, FLJ16363
Orthologs ADAMTS17 (Gallus gallus)   Adamts17 (Mus musculus)   ADAMTS17 (Bos taurus)   ADAMTS17 (Danio rerio)   Adamts17 (Rattus norvegicus)   CG14869 (Drosophila melanogaster)   adamts17 (Xenopus laevis)   ADAMTS17 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term metalloendopeptidase activity, intracellular, peptidase activity, proteinaceous extracellular matrix, metal ion binding, extracellular region, proteolysis, extracellular matrix, zinc ion binding
InterPro Term Peptidase_M12B_ADAM-TS, Peptidase_M12B_N, PLAC, ADAM_Cys-rich, ADAM_spacer1, Thrombospondin_1_rpt, Peptidase_M12B
Gene-Disease Assocation WEILL-MARCHESANI-LIKE SYNDROME
UniProt Accession Q8TE56
Search EB-eye ENSG00000140470
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-22541, E-GEOD-6573, E-GEOD-18105, E-MTAB-69, ... (12 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-22152, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, ... (18 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-5823, E-GEOD-20081, E-GEOD-19639
Ishikawa H
1
E-GEOD-20854
ANBL-6
1
1
E-MEXP-921
C7H2-R9C10
1
1
E-GEOD-22152
YCC6
1
E-GEOD-15460
DU-145
1
E-MEXP-2172
44 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-19069, E-GEOD-21668, E-GEOD-20033, ... (23 experiments)

Factor Value U/D Experiments
not specified
1
E-GEOD-18811
SCC
1
E-GEOD-19188
iPS cells from episomal vectors (Defined Factor sub-clone)
1
E-GEOD-20033
CD34+
1
1
E-AFMX-5
memory B cell
1
E-MEXP-2360
mesenchymal stem cell
1
E-GEOD-9894
35 more value(s).


Disease state

studied in E-GEOD-19743, E-GEOD-6872, E-AFMX-5, E-GEOD-15960, E-MEXP-2069, ... (24 experiments)

Factor Value U/D Experiments
control
2
E-GEOD-16363, E-GEOD-21912
juvenile idiopathic arthritis subtype rheumatoid factor polyarthritis
1
E-GEOD-13501
high-grade prostatic intraepithelial neoplasia
1
E-MEXP-1243
colorectal cancer
1
E-GEOD-15960
type I endometrial adenocarcinoma
1
E-GEOD-20854
adrenocortical adenoma
1
E-GEOD-10927
35 more value(s).


Compound treatment

studied in E-GEOD-20719, E-GEOD-15205, E-GEOD-7216, E-GEOD-6400, E-TABM-868, ... (9 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-TABM-868, E-MEXP-1958
unknown
1
E-GEOD-7307
TGF
1
1
E-GEOD-15205
TTA
1
1
E-MEXP-2590
estradiol
1
E-GEOD-20081
none
2
1
E-TABM-868, E-MEXP-1958, E-GEOD-20719
9 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-19665

Ethnic group
studied in E-GEOD-1643

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MEXP-1482, E-MTAB-108

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-GEOD-20115, E-TABM-601, E-GEOD-17347 ... (5 experiments)

Gestation age
studied in E-GEOD-14334

Histology
studied in E-TABM-234, E-TABM-276

immunoprecipitated protein
studied in E-GEOD-21918

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-GEOD-19330, E-TABM-666, ... (16 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Material type
studied in E-GEOD-9171

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-26495

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

RNAi
studied in E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-16363

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-GEOD-19246, E-GEOD-12198

Tumor grading
studied in E-GEOD-4290, E-GEOD-22541

Tumor size
studied in E-GEOD-6532

Processing time: 0.28 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM